BRIEF published on 02/10/2026 at 07:35, 4 months 13 days ago First Steps of the REVISED Clinical Study on GS010/LUMEVOQ® Clinical Study Gene Therapy GenSight Biologics LUMEVOQ Optic Neuropathy
BRIEF published on 02/10/2026 at 07:35, 4 months 13 days ago GenSight Biologics Begins REVISE Study for GS010 Therapy GenSight Biologics LHON REVISE Study GS010 Therapy 15-20 National Hospital
BRIEF published on 02/10/2026 at 07:35, 4 months 13 days ago Premiers Pas de l'Étude Clinique REVISE sur GS010/LUMEVOQ® Thérapie Génique Étude Clinique GenSight Biologics LUMEVOQ Neuropathie Optique
PRESS RELEASE published on 02/10/2026 at 07:30, 4 months 13 days ago Inside Information / Other news releases 15-20 National Hospital and GenSight Biologics treat first patient in GS010/LUMEVOQ® REVISE Study, for Leber Hereditary Optic Neuropathy. Clinical study supported by ANSM and aiming to enroll 14 patients in France GenSight Biologics LHON GS010/LUMEVOQ REVISE Study 15-20 National Hospital
PRESS RELEASE published on 02/10/2026 at 07:30, 4 months 13 days ago Informations privilégiées / Autres communiqués L'Hôpital national des 15-20 et GenSight Biologics traitent le premier patient dans l'étude REVISE de GS010/LUMEVOQ contre la neuropathie optique héréditaire de Leber en France GenSight Biologics Neuropathie Optique GS010/LUMEVOQ Hôpital Des 15-20 Étude REVISE
BRIEF published on 01/29/2026 at 00:26, 4 months 25 days ago GenSight Biologics Reports EGM Results Shareholders Capital Increase Extraordinary General Meeting GenSight Biologics Financial Authorizations
BRIEF published on 01/29/2026 at 00:26, 4 months 25 days ago GenSight Biologics publie les résultats de l'EGM Assemblée Générale Extraordinaire Actionnaires Augmentation De Capital GenSight Biologics Autorisations Financières
PRESS RELEASE published on 01/29/2026 at 00:21, 4 months 25 days ago Inside Information / Other news releases GenSight Biologics announces successful Extraordinary General Meeting approving financial authorizations renewal and clarifying rejection of 8th resolution, enhancing company's strategic flexibility Strategy Extraordinary General Meeting GenSight Biologics Gene Therapies Financial Authorizations
BRIEF published on 12/29/2025 at 08:05, 5 months 25 days ago GenSight Biologics Completes €2.9 Million Fundraising Shareholders Fundraising Gene Therapy Retinal Diseases Compassionate Use
BRIEF published on 12/29/2025 at 08:05, 5 months 25 days ago GenSight Biologics finalise une levée de fonds de 2,9 millions d'euros. Actionnaires Thérapie Génique Collecte De Fonds Maladies De La Rétine Usage Compassionnel
Published on 06/23/2026 at 16:10, 17 minutes ago Datavault AI Inc. (NASDAQ: DVLT) and WiSA Technologies Announce the Goho LS7 2.0 and 5.1 Home Theater Systems with WiSA E Wireless Connectivity
Published on 06/23/2026 at 16:00, 27 minutes ago Secure Blockchain Appoints Former Polygon Executive Steven Bryson-Haynes as CEO to Drive Enterprise AI Commercialization
Published on 06/23/2026 at 15:45, 42 minutes ago Amdocs Advances aOS Network Workflows with Live, Multivendor AI-RAN Solution and Industry Blueprint
Published on 06/23/2026 at 15:30, 57 minutes ago Silver Spruce Resources, Inc. Adds Mine Production Knowledge to the Board
Published on 06/23/2026 at 15:30, 57 minutes ago Galantas Gold Completes Transaction to Acquire Andacollo Gold
Published on 06/23/2026 at 16:15, 11 minutes ago Roubini, Longtime Crypto Skeptic, Co-Authors Whitepaper and Backs Atlas's New Digital Reserve Asset
Published on 06/23/2026 at 15:50, 36 minutes ago Vulnerability to Viability: New compact will unlock affordable finance for climate-vulnerable countries
Published on 06/23/2026 at 15:39, 47 minutes ago Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2026
Published on 06/23/2026 at 15:35, 52 minutes ago innoscripta SE décroche ses premiers clients en France et accélère son expansion à l’international
Published on 06/23/2026 at 15:44, 43 minutes ago Guillemot Corporation S.A. | Déclaration hebdomadaire des transactions sur actions propres du 15 au 19 juin 2026
Published on 06/23/2026 at 15:44, 43 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from June 15 to June 19 2026
Published on 06/23/2026 at 14:00, 2 hours 27 minutes ago Neoen remporte un contrat long terme pour une nouvelle batterie de 200 MW / 8 heures en Ontario
Published on 06/23/2026 at 14:00, 2 hours 27 minutes ago Neoen awarded long-term contract for new 200 MW / 8-hour battery in Ontario, Canada
